{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:10:42Z","timestamp":1791846642559,"version":"4.3.4"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Arrhythmogenic cardiomyopathy (ACM) is an inherited cardiac disorder that causes sudden cardiac death and progressive heart failure. Besides fibro-fatty replacement and myocyte degenerative changes, inflammatory patchy infiltrates are found in myocardial histological analysis of ACM patients. Inflammatory cells could actively participate in ACM pathogenesis, contributing to the alteration of cardiac microenvironment homeostasis, thus triggering disease evolution. In order to characterize the immune-derived mediators involved in ACM pathogenesis, peripheral blood mononuclear cells from ACM patients were characterized and compared to healthy controls\u2019 ones. Flow cytometry analysis revealed a lower frequency of CD4<jats:sup>+<\/jats:sup> T helper type 1 cells, NK cells, and terminally differentiated CD8<jats:sup>+<\/jats:sup> EMRA<jats:sup>+<\/jats:sup> T cells in ACM patients compared to age-matched controls. In contrast, a higher proportion of effector\/memory FOXP3<jats:sup>+<\/jats:sup> CCR4<jats:sup>+<\/jats:sup> CD45RO<jats:sup>+<\/jats:sup> regulatory CD4<jats:sup>+<\/jats:sup> T cells (Treg) were found in ACM patients. Single-cell RNA-seq performed on isolated memory Treg cells (mTreg) from ACM patients and healthy controls identified 6 clusters characterized by specific gene signatures related to tissue repair and immunosuppressive pathways. Notably, interleukin 32 (IL-32) was the most differentially expressed gene in ACM patients mTreg with respect to healthy controls. Treatment of human cardiac mesenchymal stromal cells with recombinant IL-32 in vitro promoted lipid droplet accumulation and collagen deposition, thus identifying IL-32 as a new potential player in the immune-mediated trigger of cardiac fibro-fatty replacement in ACM. Overall, we here provide the first complete characterization of circulating ACM immune cells, revealing an abundance of Treg. The high expression of IL-32 in ACM Treg may contribute to accelerated cardiac remodeling in ACM patients\u2019 hearts.<\/jats:p>","DOI":"10.1038\/s41419-025-07364-y","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T13:28:36Z","timestamp":1739280516000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Analysis of effector\/memory regulatory T cells from arrhythmogenic cardiomyopathy patients identified IL-32 as a novel player in ACM pathogenesis"],"prefix":"10.1038","volume":"16","author":[{"given":"Salwa","family":"Soussi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1460-7033","authenticated-orcid":false,"given":"Angela Serena","family":"Maione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Lef\u00e8vre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Pizzinat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Iacovoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Gonzalez-Fuentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Cussac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Iengo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9229-1161","authenticated-orcid":false,"given":"Yohan","family":"Santin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Tundo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Tondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Pompilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9848-8838","authenticated-orcid":false,"given":"Angelo","family":"Parini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0630-7666","authenticated-orcid":false,"given":"Victorine","family":"Douin-Echinard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Sommariva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,11]]},"reference":[{"key":"7364_CR1","doi-asserted-by":"publisher","first-page":"4782","DOI":"10.3390\/jcm10204782","volume":"10","author":"S Chen","year":"2021","unstructured":"Chen S, Chen L, Duru F, Hu S. Heart failure in patients with arrhythmogenic Cardiomyopathy. J Clin Med. 2021;10:4782.","journal-title":"J Clin Med"},{"key":"7364_CR2","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41569-023-00874-2","volume":"20","author":"K Huynh","year":"2023","unstructured":"Huynh K. Increased degradation of desmosomal proteins in ACM. Nat Rev Cardiol. 2023;20:371.","journal-title":"Nat Rev Cardiol"},{"key":"7364_CR3","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1161\/CIRCRESAHA.117.309345","volume":"121","author":"D Corrado","year":"2017","unstructured":"Corrado D, Basso C, Judge DP. Arrhythmogenic cardiomyopathy. Circ Res. 2017;121:784\u2013802.","journal-title":"Circ Res"},{"key":"7364_CR4","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1093\/eurheartj\/ehv579","volume":"37","author":"E Sommariva","year":"2016","unstructured":"Sommariva E, Brambilla S, Carbucicchio C, Gambini E, Meraviglia V, Dello Russo A, et al. Cardiac mesenchymal stromal cells are a source of adipocytes in arrhythmogenic cardiomyopathy. Eur Heart J. 2016;37:1835\u201346.","journal-title":"Eur Heart J"},{"key":"7364_CR5","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.3390\/ijms22052673","volume":"22","author":"AS Maione","year":"2021","unstructured":"Maione AS, Stadiotti I, Pilato CA, Perrucci GL, Saverio V, Catto V, et al. Excess TGF-\u03b21 drives cardiac mesenchymal stromal cells to a pro-fibrotic commitment in arrhythmogenic cardiomyopathy. Int J Mol Sci. 2021;22:2673.","journal-title":"Int J Mol Sci"},{"key":"7364_CR6","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1161\/CIRCRESAHA.111.247023","volume":"109","author":"PY Sato","year":"2011","unstructured":"Sato PY, Coombs W, Lin X, Nekrasova O, Green KJ, Isom LL, et al. Interactions between ankyrin-G, Plakophilin-2, and Connexin43 at the cardiac intercalated disc. Circ Res. 2011;109:193\u2013201.","journal-title":"Circ Res"},{"key":"7364_CR7","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1056\/NEJMra0800028","volume":"360","author":"LT Cooper","year":"2009","unstructured":"Cooper LT. Myocarditis. N Engl J Med. 2009;360:1526\u201338.","journal-title":"N Engl J Med"},{"key":"7364_CR8","doi-asserted-by":"publisher","first-page":"646","DOI":"10.3390\/biom13040646","volume":"13","author":"G Peretto","year":"2023","unstructured":"Peretto G, Sommariva E, Di Resta C, Rabino M, Villatore A, Lazzeroni D, et al. Myocardial inflammation as a manifestation of genetic cardiomyopathies: from bedside to the bench. Biomolecules. 2023;13:646.","journal-title":"Biomolecules"},{"key":"7364_CR9","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1093\/eurheartj\/12.suppl_D.22","volume":"12","author":"G Thiene","year":"1991","unstructured":"Thiene G, Corrado D, Nava A, Rossi L, Poletti A, Boffa GM, et al. Right ventricular cardiomyopathy: is there evidence of an inflammatory aetiology? Eur Heart J. 1991;12:22\u20135.","journal-title":"Eur Heart J"},{"key":"7364_CR10","doi-asserted-by":"publisher","first-page":"3000","DOI":"10.1161\/01.CIR.0000108396.65446.21","volume":"108","author":"A Tabib","year":"2003","unstructured":"Tabib A, Loire R, Chalabreysse L, Meyronnet D, Miras A, Malicier D, et al. Circumstances of death and gross and microscopic observations in a series of 200 cases of sudden death associated with arrhythmogenic right ventricular cardiomyopathy and\/or dysplasia. Circulation. 2003;108:3000\u20135.","journal-title":"Circulation"},{"key":"7364_CR11","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1056\/NEJM198801213180301","volume":"318","author":"G Thiene","year":"1988","unstructured":"Thiene G, Nava A, Corrado D, Rossi L, Pennelli N. Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med. 1988;318:129\u201333.","journal-title":"N Engl J Med"},{"key":"7364_CR12","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1161\/01.CIR.65.2.384","volume":"65","author":"FI Marcus","year":"1982","unstructured":"Marcus FI, Fontaine GH, Guiraudon G, Frank R, Laurenceau JL, Malergue C, et al. Right ventricular dysplasia: a report of 24 adult cases. Circulation. 1982;65:384\u201398.","journal-title":"Circulation"},{"key":"7364_CR13","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1016\/S0735-1097(97)00332-X","volume":"30","author":"D Corrado","year":"1997","unstructured":"Corrado D, Basso C, Thiene G, McKenna WJ, Davies MJ, Fontaliran F, et al. Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy\/dysplasia: a multicenter study. J Am Coll Cardiol. 1997;30:1512\u201320.","journal-title":"J Am Coll Cardiol"},{"key":"7364_CR14","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1136\/jclinpath-2012-201022","volume":"65","author":"O Campuzano","year":"2012","unstructured":"Campuzano O, Alcalde M, Iglesias A, Barahona-Dussault C, Sarquella-Brugada G, Benito B, et al. Arrhythmogenic right ventricular cardiomyopathy: severe structural alterations are associated with inflammation. J Clin Pathol. 2012;65:1077\u201383.","journal-title":"J Clin Pathol"},{"key":"7364_CR15","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1161\/CIRCULATIONAHA.119.040676","volume":"140","author":"SP Chelko","year":"2019","unstructured":"Chelko SP, Asimaki A, Lowenthal J, Bueno-Beti C, Bedja D, Scalco A, et al. Therapeutic modulation of the immune response in arrhythmogenic cardiomyopathy. Circulation. 2019;140:1491\u2013505.","journal-title":"Circulation"},{"key":"7364_CR16","doi-asserted-by":"crossref","unstructured":"Chelko SP, Penna VR, Engel M, Shiel EA, Centner AM, Farra W, et al. NF\u0138B signaling drives myocardial injury via CCR2+ macrophages in a preclinical model of arrhythmogenic cardiomyopathy. J Clin Invest [Internet]. 2024 Jul [cited 2024 Jul 22];134. Available from: https:\/\/www.jci.org\/articles\/view\/172014.","DOI":"10.1172\/JCI183441"},{"key":"7364_CR17","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1161\/CIRCEP.111.964890","volume":"4","author":"A Asimaki","year":"2011","unstructured":"Asimaki A, Tandri H, Duffy ER, Winterfield JR, Mackey-Bojack S, Picken MM, et al. Altered desmosomal proteins in granulomatous myocarditis and potential pathogenic links to arrhythmogenic right ventricular cardiomyopathy. Circ Arrhythm Electrophysiol. 2011;4:743\u201352.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"7364_CR18","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1007\/s00259-010-1525-y","volume":"37","author":"ME Campian","year":"2010","unstructured":"Campian ME, Verberne HJ, Hardziyenka M, de Groot EAA, van Moerkerken AF, van Eck-Smit BLF, et al. Assessment of inflammation in patients with arrhythmogenic right ventricular cardiomyopathy\/dysplasia. Eur J Nucl Med Mol Imaging. 2010;37:2079\u201385.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7364_CR19","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/ehf2.14218","volume":"10","author":"J Ren","year":"2023","unstructured":"Ren J, Chen L, Chen X, Zhang N, Sun X, Song J. Acylation-stimulating protein and heart failure progression in arrhythmogenic right ventricular cardiomyopathy. ESC Heart Fail. 2023;10:492\u2013501.","journal-title":"ESC Heart Fail"},{"key":"7364_CR20","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1093\/cvr\/cvaa084","volume":"116","author":"SM van der Voorn","year":"2020","unstructured":"van der Voorn SM, te Riele ASJM, Basso C, Calkins H, Remme CA, van Veen TAB. Arrhythmogenic cardiomyopathy: pathogenesis, pro-arrhythmic remodelling, and novel approaches for risk stratification and therapy. Cardiovasc Res. 2020;116:1571\u201384.","journal-title":"Cardiovasc Res"},{"key":"7364_CR21","doi-asserted-by":"publisher","first-page":"6500","DOI":"10.3390\/ijms22126500","volume":"22","author":"I Stadiotti","year":"2021","unstructured":"Stadiotti I, Lippi M, Maione AS, Compagnucci P, Andreini D, Casella M, et al. Cardiac biomarkers and autoantibodies in endurance athletes: potential similarities with arrhythmogenic cardiomyopathy pathogenic mechanisms. Int J Mol Sci. 2021;22:6500.","journal-title":"Int J Mol Sci"},{"key":"7364_CR22","doi-asserted-by":"publisher","first-page":"3932","DOI":"10.1093\/eurheartj\/ehy567","volume":"39","author":"D Chatterjee","year":"2018","unstructured":"Chatterjee D, Fatah M, Akdis D, Spears DA, Koopmann TT, Mittal K, et al. An autoantibody identifies arrhythmogenic right ventricular cardiomyopathy and participates in its pathogenesis. Eur Heart J. 2018;39:3932\u201344.","journal-title":"Eur Heart J"},{"key":"7364_CR23","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1161\/CIRCULATIONAHA.119.043931","volume":"141","author":"ALP Caforio","year":"2020","unstructured":"Caforio ALP, Re F, Avella A, Marcolongo R, Baratta P, Seguso M, et al. Evidence from family studies for autoimmunity in arrhythmogenic right ventricular cardiomyopathy. Circulation. 2020;141:1238\u201348.","journal-title":"Circulation"},{"key":"7364_CR24","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/s41577-018-0065-8","volume":"18","author":"FK Swirski","year":"2018","unstructured":"Swirski FK, Nahrendorf M. Cardioimmunology: the immune system in cardiac homeostasis and disease. Nat Rev Immunol. 2018;18:733\u201344.","journal-title":"Nat Rev Immunol"},{"key":"7364_CR25","doi-asserted-by":"publisher","first-page":"661","DOI":"10.3390\/biomedicines10030661","volume":"10","author":"VG Yerra","year":"2022","unstructured":"Yerra VG, Advani A. Role of CCR2-positive macrophages in pathological ventricular remodelling. Biomedicines. 2022;10:661.","journal-title":"Biomedicines"},{"key":"7364_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-024-01840-1","volume":"9","author":"R Chen","year":"2024","unstructured":"Chen R, Zhang H, Tang B, Luo Y, Yang Y, Zhong X, et al. Macrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets. Sig Transduct Target Ther. 2024;9:1\u201344.","journal-title":"Sig Transduct Target Ther"},{"key":"7364_CR27","doi-asserted-by":"publisher","first-page":"H124","DOI":"10.1152\/ajpheart.00028.2019","volume":"317","author":"RM Blanton","year":"2019","unstructured":"Blanton RM, Carrillo-Salinas FJ, Alcaide P. T-cell recruitment to the heart: friendly guests or unwelcome visitors? Am J Physiol Heart Circ. Physiol. 2019;317:H124\u201340.","journal-title":"Am J Physiol Heart Circ. Physiol"},{"key":"7364_CR28","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1007\/s10741-021-10156-z","volume":"27","author":"A Moskalik","year":"2022","unstructured":"Moskalik A, Niderla-Bieli\u0144ska J, Ratajska A. Multiple roles of cardiac macrophages in heart homeostasis and failure. Heart Fail Rev. 2022;27:1413\u201330.","journal-title":"Heart Fail Rev"},{"key":"7364_CR29","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1161\/CIRCULATIONAHA.113.007101","volume":"129","author":"F Laroumanie","year":"2014","unstructured":"Laroumanie F, Douin-Echinard V, Pozzo J, Lairez O, Tortosa F, Vinel C, et al. CD4+ T cells promote the transition from hypertrophy to heart failure during chronic pressure overload. Circulation. 2014;129:2111\u201324.","journal-title":"Circulation"},{"key":"7364_CR30","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.yjmcc.2022.09.001","volume":"173","author":"N Hapke","year":"2022","unstructured":"Hapke N, Heinrichs M, Ashour D, Vogel E, Hofmann U, Frantz S, et al. Identification of a novel cardiac epitope triggering T-cell responses in patients with myocardial infarction. J Mol Cell Cardiol. 2022;173:25\u20139.","journal-title":"J Mol Cell Cardiol"},{"key":"7364_CR31","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1161\/CIRCULATIONAHA.121.055610","volume":"146","author":"S Fanti","year":"2022","unstructured":"Fanti S, Stephenson E, Rocha-Vieira E, Protonotarios A, Kanoni S, Shahaj E, et al. Circulating c-Met-expressing memory t cells define cardiac autoimmunity. Circulation. 2022;146:1930\u201345.","journal-title":"Circulation"},{"key":"7364_CR32","doi-asserted-by":"publisher","first-page":"4891","DOI":"10.4049\/jimmunol.178.8.4891","volume":"178","author":"D Baatar","year":"2007","unstructured":"Baatar D, Olkhanud P, Sumitomo K, Taub D, Gress R, Biragyn A. Human peripheral blood T regulatory cells (Tregs), functionally primed CCR4+ Tregs and unprimed CCR4\u2212 Tregs, regulate effector T cells using FasL1. J Immunol. 2007;178:4891\u2013900.","journal-title":"J Immunol"},{"key":"7364_CR33","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1161\/CIRCULATIONAHA.118.036065","volume":"139","author":"SS Bansal","year":"2019","unstructured":"Bansal SS, Ismahil MA, Goel M, Zhou G, Rokosh G, Hamid T, et al. Dysfunctional and proinflammatory regulatory T-lymphocytes are essential for adverse cardiac remodeling in ischemic cardiomyopathy. Circulation. 2019;139:206\u201321.","journal-title":"Circulation"},{"key":"7364_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04908-z","volume":"9","author":"S Zacchigna","year":"2018","unstructured":"Zacchigna S, Martinelli V, Moimas S, Colliva A, Anzini M, Nordio A, et al. Paracrine effect of regulatory T cells promotes cardiomyocyte proliferation during pregnancy and after myocardial infarction. Nat Commun. 2018;9:2432.","journal-title":"Nat Commun"},{"key":"7364_CR35","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1189\/jlb.5A1014-469RR","volume":"97","author":"ZF Zhu","year":"2015","unstructured":"Zhu ZF, Tang TT, Dong WY, Li YY, Xia N, Zhang WC, et al. Defective circulating CD4+LAP+ regulatory T cells in patients with dilated cardiomyopathy. J Leukoc Biol. 2015;97:797\u2013805.","journal-title":"J Leukoc Biol"},{"key":"7364_CR36","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3349\/ymj.2019.60.2.126","volume":"60","author":"MK Jung","year":"2019","unstructured":"Jung MK, Lee JS, Kwak JE, Shin EC. Tumor necrosis factor and regulatory T cells. Yonsei Med J. 2019;60:126\u201331.","journal-title":"Yonsei Med J"},{"key":"7364_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-26688-9","volume":"13","author":"M Boidin","year":"2023","unstructured":"Boidin M, Lip GYH, Shantsila A, Thijssen D, Shantsila E. Dynamic changes of monocytes subsets predict major adverse cardiovascular events and left ventricular function after STEMI. Sci Rep. 2023;13:48.","journal-title":"Sci Rep"},{"key":"7364_CR38","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1093\/cvr\/cvad069","volume":"119","author":"AV Ruder","year":"2023","unstructured":"Ruder AV, Wetzels SMW, Temmerman L, Biessen EAL, Goossens P. Monocyte heterogeneity in cardiovascular disease. Cardiovasc. Res. 2023;119:2033\u201345.","journal-title":"Cardiovasc. Res"},{"key":"7364_CR39","doi-asserted-by":"crossref","unstructured":"Mengos AE, Gastineau DA, Gustafson MP. The CD14+HLA-DRlo\/neg monocyte: an immunosuppressive phenotype that restrains responses to cancer immunotherapy. frontiers in immunology [Internet]. 2019 [cited 2023 Jul 4];10. Available from: https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2019.01147.","DOI":"10.3389\/fimmu.2019.01147"},{"key":"7364_CR40","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1038\/s41591-020-1038-6","volume":"26","author":"AG Laing","year":"2020","unstructured":"Laing AG, Lorenc A, Del Molino Del Barrio I, Das A, Fish M, Monin L, et al. A dynamic COVID-19 immune signature includes associations with poor prognosis. Nat Med. 2020;26:1623\u201335.","journal-title":"Nat Med"},{"key":"7364_CR41","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.immuni.2019.01.020","volume":"50","author":"JB Wing","year":"2019","unstructured":"Wing JB, Tanaka A, Sakaguchi S. Human FOXP3+ regulatory T cell heterogeneity and function in autoimmunity and cancer. Immunity. 2019;50:302\u201316.","journal-title":"Immunity"},{"key":"7364_CR42","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.immuni.2018.04.008","volume":"48","author":"E Cuadrado","year":"2018","unstructured":"Cuadrado E, van den Biggelaar M, de Kivit S, Chen Yyen, Slot M, Doubal I, et al. Proteomic analyses of human regulatory T cells reveal adaptations in signaling pathways that protect cellular identity. Immunity. 2018;48:1046\u201359.e6.","journal-title":"Immunity"},{"key":"7364_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24213-6","volume":"12","author":"Y Luo","year":"2021","unstructured":"Luo Y, Xu C, Wang B, Niu Q, Su X, Bai Y, et al. Single-cell transcriptomic analysis reveals disparate effector differentiation pathways in human Treg compartment. Nat Commun. 2021;12:3913.","journal-title":"Nat Commun"},{"key":"7364_CR44","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.celrep.2017.06.079","volume":"20","author":"L Halim","year":"2017","unstructured":"Halim L, Romano M, McGregor R, Correa I, Pavlidis P, Grageda N, et al. An atlas of human regulatory T helper-like cells reveals features of Th2-like Tregs that support a tumorigenic environment. Cell Rep. 2017;20:757\u201370.","journal-title":"Cell Rep"},{"key":"7364_CR45","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/nmeth.4380","volume":"14","author":"M Stoeckius","year":"2017","unstructured":"Stoeckius M, Hafemeister C, Stephenson W, Houck-Loomis B, Chattopadhyay PK, Swerdlow H, et al. Simultaneous epitope and transcriptome measurement in single cells. Nat Methods. 2017;14:865\u20138.","journal-title":"Nat Methods"},{"key":"7364_CR46","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1016\/j.cell.2018.10.022","volume":"175","author":"BJ Schmiedel","year":"2018","unstructured":"Schmiedel BJ, Singh D, Madrigal A, Valdovino-Gonzalez AG, White BM, Zapardiel-Gonzalo J, et al. Impact of genetic polymorphisms on human immune cell gene expression. Cell. 2018;175:1701\u201315.e16.","journal-title":"Cell"},{"key":"7364_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.xgen.2023.100473","volume":"4","author":"Y Yasumizu","year":"2024","unstructured":"Yasumizu Y, Takeuchi D, Morimoto R, Takeshima Y, Okuno T, Kinoshita M, et al. Single-cell transcriptome landscape of circulating CD4+ T cell populations in autoimmune diseases. Cell Genom. 2024;4:100473.","journal-title":"Cell Genom"},{"key":"7364_CR48","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41590-018-0051-0","volume":"19","author":"D Zemmour","year":"2018","unstructured":"Zemmour D, Zilionis R, Kiner E, Klein AM, Mathis D, Benoist C. Single-cell gene expression reveals a landscape of regulatory T cell phenotypes shaped by the TCR. Nat Immunol. 2018;19:291\u2013301.","journal-title":"Nat Immunol"},{"key":"7364_CR49","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.2337\/db15-0572","volume":"65","author":"AM Pesenacker","year":"2016","unstructured":"Pesenacker AM, Wang AY, Singh A, Gillies J, Kim Y, Piccirillo CA, et al. A regulatory T-cell gene signature is a specific and sensitive biomarker to identify children with new-onset type 1 diabetes. Diabetes. 2016;65:1031\u20139.","journal-title":"Diabetes"},{"key":"7364_CR50","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2111315118","volume":"118","author":"S Galv\u00e1n-Pe\u00f1a","year":"2021","unstructured":"Galv\u00e1n-Pe\u00f1a S, Leon J, Chowdhary K, Michelson DA, Vijaykumar B, Yang L, et al. Profound Treg perturbations correlate with COVID-19 severity. Proc Natl Acad Sci USA. 2021;118:e2111315118.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7364_CR51","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.immuni.2019.01.001","volume":"50","author":"RJ Miragaia","year":"2019","unstructured":"Miragaia RJ, Gomes T, Chomka A, Jardine L, Riedel A, Hegazy AN, et al. Single-cell transcriptomics of regulatory T cells reveals trajectories of tissue adaptation. Immunity. 2019;50:493\u2013504.e7.","journal-title":"Immunity"},{"key":"7364_CR52","doi-asserted-by":"publisher","first-page":"2918","DOI":"10.1016\/j.cell.2022.06.018","volume":"185","author":"AM Luoma","year":"2022","unstructured":"Luoma AM, Suo S, Wang Y, Gunasti L, Porter CBM, Nabilsi N, et al. Tissue-resident memory and circulating T cells are early responders to pre-surgical cancer immunotherapy. Cell. 2022;185:2918\u201335.e29.","journal-title":"Cell"},{"key":"7364_CR53","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.coi.2011.07.002","volume":"23","author":"UH Beier","year":"2011","unstructured":"Beier UH, Akimova T, Liu Y, Wang L, Hancock WW. Histone\/protein deacetylases control Foxp3 expression and the heat shock response of T-regulatory cells. Curr Opin Immunol. 2011;23:670\u20138.","journal-title":"Curr Opin Immunol"},{"key":"7364_CR54","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1016\/j.cmet.2023.08.010","volume":"35","author":"M Becker","year":"2023","unstructured":"Becker M, Joseph SS, Garcia-Carrizo F, Tom RZ, Opaleva D, Serr I, et al. Regulatory T cells require IL6 receptor alpha signaling to control skeletal muscle function and regeneration. Cell Metab. 2023;35:1736\u201351.e7.","journal-title":"Cell Metab"},{"key":"7364_CR55","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adf6717","volume":"8","author":"F Shan","year":"2023","unstructured":"Shan F, Cillo AR, Cardello C, Yuan DY, Kunning SR, Cui J, et al. Integrated BATF transcriptional network regulates suppressive intratumoral regulatory T cells. Sci Immunol. 2023;8:eadf6717.","journal-title":"Sci Immunol"},{"key":"7364_CR56","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/j.immuni.2024.05.023","volume":"57","author":"OT Burton","year":"2024","unstructured":"Burton OT, Bricard O, Tareen S, Gergelits V, Andrews S, Biggins L, et al. The tissue-resident regulatory T cell pool is shaped by transient multi-tissue migration and a conserved residency program. Immunity. 2024;57:1586\u2013602.e10.","journal-title":"Immunity"},{"key":"7364_CR57","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1161\/CIRCULATIONAHA.121.055890","volume":"144","author":"B Asatryan","year":"2021","unstructured":"Asatryan B, Asimaki A, Landstrom AP, Khanji MY, Odening KE, Cooper LT, et al. Inflammation and immune response in arrhythmogenic cardiomyopathy: state-of-the-art review. Circulation. 2021;144:1646\u201355.","journal-title":"Circulation"},{"key":"7364_CR58","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41577-022-00761-w","volume":"23","author":"H Du","year":"2023","unstructured":"Du H, Bartleson JM, Butenko S, Alonso V, Liu WF, Winer DA, et al. Tuning immunity through tissue mechanotransduction. Nat Rev Immunol. 2023;23:174\u201388.","journal-title":"Nat Rev Immunol"},{"key":"7364_CR59","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.ccell.2023.04.003","volume":"41","author":"A Obradovic","year":"2023","unstructured":"Obradovic A, Ager C, Turunen M, Nirschl T, Khosravi-Maharlooei M, Iuga A, et al. Systematic elucidation and pharmacological targeting of tumor-infiltrating regulatory T cell master regulators. Cancer Cell. 2023;41:933\u201349.e11.","journal-title":"Cancer Cell"},{"key":"7364_CR60","doi-asserted-by":"publisher","first-page":"102461","DOI":"10.1016\/j.jaut.2020.102461","volume":"111","author":"X Zhang","year":"2020","unstructured":"Zhang X, Olsen N, Zheng SG. The progress and prospect of regulatory T cells in autoimmune diseases. J Autoimmun. 2020;111:102461.","journal-title":"J Autoimmun"},{"key":"7364_CR61","doi-asserted-by":"publisher","first-page":"eabo1984","DOI":"10.1126\/science.abo1984","volume":"377","author":"D Reichart","year":"2022","unstructured":"Reichart D, Lindberg EL, Maatz H, Miranda AMA, Viveiros A, Shvetsov N, et al. Pathogenic variants damage cell composition and single cell transcription in cardiomyopathies. Science. 2022;377:eabo1984.","journal-title":"Science"},{"key":"7364_CR62","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.stem.2020.05.004","volume":"26","author":"E Giacomelli","year":"2020","unstructured":"Giacomelli E, Meraviglia V, Campostrini G, Cochrane A, Cao X, van Helden RWJ, et al. Human-iPSC-derived cardiac stromal cells enhance maturation in 3D cardiac microtissues and reveal non-cardiomyocyte contributions to heart disease. Cell Stem Cell. 2020;26:862\u201379.e11.","journal-title":"Cell Stem Cell"},{"key":"7364_CR63","doi-asserted-by":"publisher","first-page":"813","DOI":"10.3390\/biomedicines11030813","volume":"11","author":"SM van der Voorn","year":"2023","unstructured":"van der Voorn SM, Bourfiss M, Muller SA, \u00c7imen T, Saguner AM, Duru F, et al. Circulating biomarkers of fibrosis formation in patients with arrhythmogenic cardiomyopathy. Biomedicines. 2023;11:813.","journal-title":"Biomedicines"},{"key":"7364_CR64","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.784715","volume":"8","author":"V Meraviglia","year":"2021","unstructured":"Meraviglia V, Alcalde M, Campuzano O, Bellin M. Inflammation in the pathogenesis of arrhythmogenic cardiomyopathy: secondary event or active driver? Front Cardiovasc Med. 2021;8:784715.","journal-title":"Front Cardiovasc Med"},{"key":"7364_CR65","doi-asserted-by":"publisher","first-page":"3311","DOI":"10.1084\/jem.20161791","volume":"214","author":"T Nevers","year":"2017","unstructured":"Nevers T, Salvador AM, Velazquez F, Ngwenyama N, Carrillo-Salinas FJ, Aronovitz M, et al. Th1 effector T cells selectively orchestrate cardiac fibrosis in nonischemic heart failure. J Exp Med. 2017;214:3311\u201329.","journal-title":"J Exp Med"},{"key":"7364_CR66","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cmet.2019.09.010","volume":"31","author":"C Campbell","year":"2020","unstructured":"Campbell C, Rudensky A. Roles of regulatory T cells in tissue pathophysiology and metabolism. Cell Metab. 2020;31:18\u201325.","journal-title":"Cell Metab"},{"key":"7364_CR67","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/s41385-021-00456-w","volume":"15","author":"L Barros","year":"2022","unstructured":"Barros L, Ferreira C, Veldhoen M. The fellowship of regulatory and tissue-resident memory cells. Mucosal Immunol. 2022;15:64\u201373.","journal-title":"Mucosal Immunol"},{"key":"7364_CR68","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.immuni.2018.07.015","volume":"49","author":"JD Proto","year":"2018","unstructured":"Proto JD, Doran AC, Gusarova G, Yurdagul A, Sozen E, Subramanian M, et al. Regulatory T cells promote macrophage efferocytosis during inflammation resolution. Immunity. 2018;49:666\u2013677.e6.","journal-title":"Immunity"},{"key":"7364_CR69","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.immuni.2008.02.017","volume":"28","author":"YP Rubtsov","year":"2008","unstructured":"Rubtsov YP, Rasmussen JP, Chi EY, Fontenot J, Castelli L, Ye X, et al. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity. 2008;28:546\u201358.","journal-title":"Immunity"},{"key":"7364_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-022-05142-8","volume":"13","author":"J Wu","year":"2022","unstructured":"Wu J, Ren B, Wang D, Lin H. Regulatory T cells in skeletal muscle repair and regeneration: recent insights. Cell Death Dis. 2022;13:1\u201311.","journal-title":"Cell Death Dis"},{"key":"7364_CR71","doi-asserted-by":"crossref","unstructured":"Li J, Tan J, Martino MM, Lui KO. Regulatory T-cells: potential regulator of tissue repair and regeneration. front immunol [Internet]. 2018 Mar [cited 2024 Jul 22];9. Available from: https:\/\/www.frontiersin.org\/journals\/immunology\/articles\/10.3389\/fimmu.2018.00585\/full.","DOI":"10.3389\/fimmu.2018.00585"},{"key":"7364_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50806-y","volume":"15","author":"YK Alshoubaki","year":"2024","unstructured":"Alshoubaki YK, Nayer B, Lu YZ, Salimova E, Lau SN, Tan JL, et al. Tregs delivered post-myocardial infarction adopt an injury-specific phenotype promoting cardiac repair via macrophages in mice. Nat Commun. 2024;15:6480.","journal-title":"Nat Commun"},{"key":"7364_CR73","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41577-021-00519-w","volume":"21","author":"AR Mu\u00f1oz-Rojas","year":"2021","unstructured":"Mu\u00f1oz-Rojas AR, Mathis D. Tissue regulatory T cells: regulatory chameleons. Nat Rev Immunol. 2021;21:597\u2013611.","journal-title":"Nat Rev Immunol"},{"key":"7364_CR74","doi-asserted-by":"crossref","unstructured":"Beffagna G, Sommariva E, Bellin M. Mechanotransduction and adrenergic stimulation in arrhythmogenic cardiomyopathy: an overview of in vitro and in vivo models. Front Physiol [Internet]. 2020 Nov [cited 2024 Jul 22];11. Available from: https:\/\/www.frontiersin.org\/journals\/physiology\/articles\/10.3389\/fphys.2020.568535\/full.","DOI":"10.3389\/fphys.2020.568535"},{"key":"7364_CR75","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3389\/fphys.2020.00279","volume":"11","author":"AS Maione","year":"2020","unstructured":"Maione AS, Pilato CA, Casella M, Gasperetti A, Stadiotti I, Pompilio G, et al. Fibrosis in Arrhythmogenic Cardiomyopathy: The Phantom Thread in the Fibro-Adipose Tissue. Front Physiol. 2020;11:279.","journal-title":"Front Physiol"},{"key":"7364_CR76","doi-asserted-by":"crossref","unstructured":"Zhang XZ, Zhang S, Tang TT, Cheng X. Bioinformatics and immune infiltration analyses reveal the key pathway and immune cells in the pathogenesis of hypertrophic cardiomyopathy. Front Cardiovasc Med [Internet]. 2021 Aug [cited 2024 Jul 22];8. Available from: https:\/\/www.frontiersin.org\/journals\/cardiovascular-medicine\/articles\/10.3389\/fcvm.2021.696321\/full.","DOI":"10.3389\/fcvm.2021.696321"},{"key":"7364_CR77","doi-asserted-by":"publisher","first-page":"6785","DOI":"10.1074\/jbc.RA118.006255","volume":"294","author":"Z Zhao","year":"2019","unstructured":"Zhao Z, Lan M, Li J, Dong Q, Li X, Liu B, et al. The proinflammatory cytokine TNF\u03b1 induces DNA demethylation-dependent and -independent activation of interleukin-32 expression. J Biol Chem. 2019;294:6785\u201395.","journal-title":"J Biol Chem"},{"key":"7364_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/srep11063","volume":"5","author":"B Meyer","year":"2015","unstructured":"Meyer B, Chavez RA, Munro JE, Chiaroni-Clarke RC, Akikusa JD, Allen RC, et al. DNA methylation at IL32 in juvenile idiopathic arthritis. Sci Rep. 2015;5:11063.","journal-title":"Sci Rep"},{"key":"7364_CR79","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s41232-021-00164-9","volume":"41","author":"H Hao","year":"2021","unstructured":"Hao H, Nakayamada S, Tanaka Y. Differentiation, functions, and roles of T follicular regulatory cells in autoimmune diseases. Inflamm Regen. 2021;41:14.","journal-title":"Inflamm Regen"},{"key":"7364_CR80","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.ijcard.2017.03.065","volume":"243","author":"W Xuan","year":"2017","unstructured":"Xuan W, Huang W, Wang R, Chen C, Chen Y, Wang Y, et al. Elevated circulating IL-32 presents a poor prognostic outcome in patients with heart failure after myocardial infarction. Int J Cardiol. 2017;243:367\u201373.","journal-title":"Int J Cardiol"},{"key":"7364_CR81","doi-asserted-by":"publisher","first-page":"iii61","DOI":"10.1136\/ard.2006.058511","volume":"65","author":"CA Dinarello","year":"2006","unstructured":"Dinarello CA, Kim SH. IL-32, a novel cytokine with a possible role in disease. Ann Rheum Dis. 2006;65:iii61\u20134.","journal-title":"Ann Rheum Dis"},{"key":"7364_CR82","first-page":"2941","volume":"35","author":"B Nabeki","year":"2015","unstructured":"Nabeki B, Ishigami S, Uchikado Y, Sasaki K, Kita Y, Okumura H, et al. Interleukin-32 expression and Treg infiltration in esophageal squamous cell carcinoma. Anticancer Res. 2015;35:2941\u20137.","journal-title":"Anticancer Res"},{"key":"7364_CR83","doi-asserted-by":"crossref","unstructured":"Han L, Chen S, Chen Z, Zhou B, Zheng Y, Shen L. Interleukin 32 promotes Foxp3+ Treg cell development and CD8+ T cell function in human esophageal squamous cell carcinoma microenvironment. Front Cell Dev Biol [Internet]. 2021 [cited 2023 Jun 28];9. Available from: https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2021.704853.","DOI":"10.3389\/fcell.2021.704853"},{"key":"7364_CR84","doi-asserted-by":"publisher","first-page":"154793","DOI":"10.1016\/j.cyto.2019.154793","volume":"125","author":"MSMA Damen","year":"2020","unstructured":"Damen MSMA, Ballak D, Sapinsley Z, Bai X, Chan ED, Seals DR, et al. Transgenic mice expressing human IL-32 develop adipokine profiles resembling those of obesity-induced metabolic changes. Cytokine. 2020;125:154793.","journal-title":"Cytokine"},{"key":"7364_CR85","doi-asserted-by":"publisher","first-page":"21082","DOI":"10.1073\/pnas.1015418107","volume":"107","author":"J Choi","year":"2010","unstructured":"Choi J, Bae S, Hong J, Ryoo S, Jhun H, Hong K, et al. Paradoxical effects of constitutive human IL-32\u03b3 in transgenic mice during experimental colitis. Proc Natl Acad Sci USA. 2010;107:21082\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7364_CR86","doi-asserted-by":"publisher","first-page":"4962","DOI":"10.1073\/pnas.1016005108","volume":"108","author":"B Heinhuis","year":"2011","unstructured":"Heinhuis B, Koenders MI, van de Loo FA, Netea MG, van den Berg WB, Joosten LAB. Inflammation-dependent secretion and splicing of IL-32\u03b3 in rheumatoid arthritis. Proc Natl Acad Sci USA. 2011;108:4962\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7364_CR87","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/j.1365-2567.2008.02917.x","volume":"126","author":"JD Choi","year":"2009","unstructured":"Choi JD, Bae SY, Hong JW, Azam T, Dinarello CA, Her E, et al. Identification of the most active interleukin-32 isoform. Immunology. 2009;126:535\u201342.","journal-title":"Immunology"},{"key":"7364_CR88","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.cyto.2012.07.010","volume":"60","author":"B Heinhuis","year":"2012","unstructured":"Heinhuis B, Netea MG, van den Berg WB, Dinarello CA, Joosten LAB. Interleukin-32: a predominantly intracellular proinflammatory mediator that controls cell activation and cell death. Cytokine. 2012;60:321\u20137.","journal-title":"Cytokine"},{"key":"7364_CR89","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1093\/carcin\/bgv172","volume":"37","author":"B Heinhuis","year":"2016","unstructured":"Heinhuis B, Plantinga TS, Semango G, K\u00fcsters B, Netea MG, Dinarello CA, et al. Alternatively spliced isoforms of IL-32 differentially influence cell death pathways in cancer cell lines. Carcinogenesis. 2016;37:197\u2013205.","journal-title":"Carcinogenesis"},{"key":"7364_CR90","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/s41420-024-02232-8","volume":"10","author":"AS Maione","year":"2024","unstructured":"Maione AS, Iengo L, Sala L, Massaiu I, Chiesa M, Lippi M, et al. Cardiomyocyte and stromal cell cross-talk influences the pathogenesis of arrhythmogenic cardiomyopathy: a multi-level analysis uncovers DLK1-NOTCH pathway role in fibro-adipose remodelling. Cell Death Discov. 2024;10:484.","journal-title":"Cell Death Discov"},{"key":"7364_CR91","doi-asserted-by":"publisher","DOI":"10.1155\/2024\/6693292","volume":"2024","author":"X Zhang","year":"2024","unstructured":"Zhang X, Zheng Y, Wang G, Liu Y, Wang Y, Jiang X, et al. Stimulated human umbilical cord mesenchymal stem cells enhance the osteogenesis and cranial bone regeneration through IL-32 mediated P38 signaling pathway. Stem Cells Int. 2024;2024:6693292.","journal-title":"Stem Cells Int"},{"key":"7364_CR92","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-020-01319-z","volume":"20","author":"L Gong","year":"2020","unstructured":"Gong L, Liu G, Zhu H, Li C, Li P, Liu C, et al. IL-32 induces epithelial-mesenchymal transition by triggering endoplasmic reticulum stress in A549 cells. BMC Pulm Med. 2020;20:278.","journal-title":"BMC Pulm Med"},{"key":"7364_CR93","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1093\/eurheartj\/ehp249","volume":"30","author":"A Frustaci","year":"2009","unstructured":"Frustaci A, Russo MA, Chimenti C. Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study. Eur Heart J. 2009;30:1995\u20132002.","journal-title":"Eur Heart J"},{"key":"7364_CR94","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.jacep.2020.05.013","volume":"6","author":"G Peretto","year":"2020","unstructured":"Peretto G, Sala S, De Luca G, Marcolongo R, Campochiaro C, Sartorelli S, et al. Immunosuppressive therapy and risk stratification of patients with myocarditis presenting with ventricular arrhythmias. JACC Clin Electrophysiol. 2020;6:1221\u201334.","journal-title":"JACC Clin Electrophysiol"},{"key":"7364_CR95","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.jacep.2022.10.032","volume":"9","author":"G Peretto","year":"2023","unstructured":"Peretto G, Casella M, Merlo M, Benedetti S, Rizzo S, Cappelletto C, et al. Inflammation on endomyocardial biopsy predicts risk of MACE in Undefined left ventricular arrhythmogenic cardiomyopathy. JACC Clin Electrophysiol. 2023;9:951\u201361.","journal-title":"JACC Clin Electrophysiol"},{"key":"7364_CR96","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1126\/science.aau2688","volume":"362","author":"JA Bluestone","year":"2018","unstructured":"Bluestone JA, Tang Q. Treg cells-the next frontier of cell therapy. Science. 2018;362:154\u20135.","journal-title":"Science"},{"key":"7364_CR97","doi-asserted-by":"publisher","first-page":"9676","DOI":"10.3390\/ijms22189676","volume":"22","author":"M Hefazi","year":"2021","unstructured":"Hefazi M, Bolivar-Wagers S, Blazar BR. Regulatory T cell therapy of graft-versus-host disease: advances and challenges. Int J Mol Sci. 2021;22:9676.","journal-title":"Int J Mol Sci"},{"key":"7364_CR98","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20231045","volume":"220","author":"E Bernaldo-de-Quir\u00f3s","year":"2023","unstructured":"Bernaldo-de-Quir\u00f3s E, Camino M, Mart\u00ednez-Bonet M, Gil-Jaurena JM, Gil N, Hern\u00e1ndez-Fl\u00f3rez D, et al. First-in-human therapy with Treg produced from thymic tissue (thyTreg) in a heart transplant infant. J Exp Med. 2023;220:e20231045.","journal-title":"J Exp Med"},{"key":"7364_CR99","doi-asserted-by":"crossref","unstructured":"Pilato CA, Stadiotti I, Maione AS, Saverio V, Catto V, Tundo F, et al. Isolation and characterization of cardiac mesenchymal stromal cells from endomyocardial bioptic samples of arrhythmogenic cardiomyopathy patients. J Vis Exp. 2018;28:57263.","DOI":"10.3791\/57263"},{"key":"7364_CR100","doi-asserted-by":"publisher","first-page":"589","DOI":"10.4049\/jimmunol.1202802","volume":"192","author":"CA Nold-Petry","year":"2014","unstructured":"Nold-Petry CA, Rudloff I, Baumer Y, Ruvo M, Marasco D, Botti P, et al. IL-32 promotes angiogenesis. J Immunol. 2014;192:589\u2013602.","journal-title":"J Immunol"},{"key":"7364_CR101","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.cyto.2013.09.017","volume":"65","author":"Q Zeng","year":"2014","unstructured":"Zeng Q, Li S, Zhou Y, Ou W, Cai X, Zhang L, et al. Interleukin-32 contributes to invasion and metastasis of primary lung adenocarcinoma via NF-kappaB induced matrix metalloproteinases 2 and 9 expression. Cytokine. 2014;65:24\u201332.","journal-title":"Cytokine"},{"key":"7364_CR102","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1038\/s41596-021-00497-2","volume":"16","author":"G Campostrini","year":"2021","unstructured":"Campostrini G, Meraviglia V, Giacomelli E, van Helden RWJ, Yiangou L, Davis RP, et al. Generation, functional analysis and applications of isogenic three-dimensional self-aggregating cardiac microtissues from human pluripotent stem cells. Nat Protoc. 2021;16:2213\u201356.","journal-title":"Nat Protoc"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07364-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07364-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07364-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T15:52:37Z","timestamp":1739461957000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07364-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,11]]},"references-count":102,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7364"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-07364-y","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,11]]},"assertion":[{"value":"27 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"87"}}